Biropharma

Biropharma is a Hungarian biotechnology company specializing in the development and production of pharmaceutical products and dietary supplements, most notably the fermented wheat germ extract known as Avemar. Founded in 1998, the company focuses on supportive cancer therapy and immune system modulation. Its flagship product, Avemar, has been extensively studied for its ability to inhibit tumor cell metabolism and enhance the efficacy of standard oncological treatments. Biropharma operates its own GMP-certified manufacturing facility in Kunfehértó, Hungary, where it produces both finished products and active ingredients. The company's research and development efforts are centered on natural substances with significant biological activity for use in oncology and autoimmune diseases.